These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 16368478

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence of erythromycin and clindamycin resistance among Streptococcus agalactiae isolates in Germany.
    Schoening TE, Wagner J, Arvand M.
    Clin Microbiol Infect; 2005 Jul; 11(7):579-82. PubMed ID: 15966978
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains.
    Domelier AS, van der Mee-Marquet N, Arnault L, Mereghetti L, Lanotte P, Rosenau A, Lartigue MF, Quentin R.
    J Antimicrob Chemother; 2008 Dec; 62(6):1227-33. PubMed ID: 18786936
    [Abstract] [Full Text] [Related]

  • 5. Identification of an erm(T) gene in strains of inducibly clindamycin-resistant group B Streptococcus.
    Dipersio LP, Dipersio JR.
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):189-93. PubMed ID: 16989973
    [Abstract] [Full Text] [Related]

  • 6. Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae.
    Culebras E, Rodríguez-Avial I, Betriu C, Picazo JJ.
    J Antimicrob Chemother; 2005 Nov; 56(5):836-40. PubMed ID: 16186169
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and mechanisms of erythromycin resistance in Streptococcus agalactiae from healthy pregnant women.
    Pinheiro S, Radhouani H, Coelho C, Gonçalves A, Carvalho E, Carvalho JA, Ruiz-Larrea F, Torres C, Igrejas G, Poeta P.
    Microb Drug Resist; 2009 Jun; 15(2):121-4. PubMed ID: 19432524
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous detection of nine antibiotic resistance-related genes in Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization assay.
    Zeng X, Kong F, Wang H, Darbar A, Gilbert GL.
    Antimicrob Agents Chemother; 2006 Jan; 50(1):204-9. PubMed ID: 16377687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rise of Streptococcus pneumoniae isolates containing both erm(B) and mef(E) genes from an adult tertiary care community hospital system.
    DiPersio LP, DiPersio JR, Beach JA, DeFine LA.
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):327-31. PubMed ID: 16626911
    [Abstract] [Full Text] [Related]

  • 11. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [Abstract] [Full Text] [Related]

  • 12. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands.
    Muller AE, Valkenburg-van den Berg AW, Kreft D, Oostvogel PM, Sprij AJ, van Belkum A.
    Eur J Obstet Gynecol Reprod Biol; 2008 Mar; 137(1):17-20. PubMed ID: 17482748
    [Abstract] [Full Text] [Related]

  • 13. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
    Malbruny B, Werno AM, Anderson TP, Murdoch DR, Leclercq R.
    J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
    [Abstract] [Full Text] [Related]

  • 14. First clinical isolate in Europe of clindamycin-resistant group B Streptococcus mediated by the lnu(B) gene.
    Arana DM, Rojo-Bezares B, Torres C, Alós JI.
    Rev Esp Quimioter; 2014 Jun; 27(2):106-9. PubMed ID: 24940891
    [Abstract] [Full Text] [Related]

  • 15. Invasive neonatal GBS infections from an area-based surveillance study in Italy.
    Imperi M, Gherardi G, Berardi A, Baldassarri L, Pataracchia M, Dicuonzo G, Orefici G, Creti R.
    Clin Microbiol Infect; 2011 Dec; 17(12):1834-9. PubMed ID: 21722258
    [Abstract] [Full Text] [Related]

  • 16. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A, Maeda Y, Goldsmith CE, Coulter WA, Mason C, Millar BC, McCalmont M, Rendall J, Elborn JS, Matsuda M, Moore JE.
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [Abstract] [Full Text] [Related]

  • 17. [Streptococcus agalactiae increase in resistance to erythromycin and clindamycin in vaginal-anal colonization in third quarter of pregnancy in one decade of universal screening].
    Abarzúa F, Arias A, García P, Ralph C, Cerda J, Riedel I, Gárate C.
    Rev Chilena Infectol; 2011 Aug; 28(4):334-7. PubMed ID: 22052397
    [Abstract] [Full Text] [Related]

  • 18. Streptococcus agalactiae in a large Portuguese teaching hospital: antimicrobial susceptibility, serotype distribution, and clonal analysis of macrolide-resistant isolates.
    Figueira-Coelho J, Ramirez M, Salgado MJ, Melo-Cristino J.
    Microb Drug Resist; 2004 Aug; 10(1):31-6. PubMed ID: 15140391
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada.
    de Azavedo JC, McGavin M, Duncan C, Low DE, McGeer A.
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3504-8. PubMed ID: 11709331
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.